HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of spirogermanium for treatment of advanced breast cancer.

AuthorsG Falkson, H C Falkson
JournalCancer treatment reports (Cancer Treat Rep) Vol. 67 Issue 2 Pg. 189-90 (Feb 1983) ISSN: 0361-5960 [Print] United States
PMID6825129 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Bone Neoplasms (secondary)
  • Breast Neoplasms (drug therapy)
  • Drug Evaluation
  • Female
  • Germanium (adverse effects, therapeutic use)
  • Humans
  • Middle Aged
  • Organometallic Compounds
  • Spiro Compounds (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: